Imatinib's Effect on Etoposide and Ifosfamide in Cancer Treatment
Author Information
Author(s): Rezaï Keyvan, Lokiec François, Grandjean Isabelle, Weill Sophie, de Cremoux Patricia, Bordier Vincent, Ekue Richard, Garcia Mickael, Poupon Marie-France, Decaudin Didier
Primary Institution: Institut Curie, Paris, France
Hypothesis
Does imatinib enhance the pharmacokinetics and efficacy of etoposide and ifosfamide in cancer treatment?
Conclusion
Imatinib increases the effectiveness of etoposide in certain cancers, justifying further clinical trials.
Supporting Evidence
- Imatinib increased the AUC of etoposide in mice.
- Concomitant administration of imatinib and etoposide enhanced tumor growth inhibition in lymphoma models.
- Imatinib did not significantly affect the urinary excretion of etoposide.
Takeaway
Imatinib helps make cancer drugs like etoposide work better, which could help people with certain types of cancer.
Methodology
The study used human tumor xenografts in mice to evaluate the effects of imatinib on chemotherapy.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Female nude or SCID mice, 6–8 weeks old.
Statistical Information
P-Value
0.025
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website